Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Medable Introduces Automation Technology for Clinical Trials Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News

Medable Introduces Automation Technology for Clinical Trials Platform

Aims to save time and remove electronic clinical outcomes assessment (eCOA) from the critical path to trial go-live.

By: Anthony Vecchione

Medable Inc., a technology provider for clinical trials, introduced a new automation technology applied across its clinical trials platform that is designed to cut standard trial build timelines.

By automating manual tasks such as testing, Medable’s new technology aims to save time and remove electronic clinical outcomes assessment (eCOA) from the critical path to trial go-live. With new AI and automations capabilities, the technology aims to eliminate common gridlocks caused by conversion, configuration, validation, and quality engineering.

Medable’s updated eCOA capabilities include an auto-configuration tool that produces standard configurations, such as schedules of assessments, anchor dates, and patient flags. Medable’s auto-validate tool is designed to automatically deliver a downloadable configuration validation report (CVR) that validates the quality of study builds.

“We are reimagining the way clinical trials are deployed by eliminating many of the biggest process bottlenecks,” said Michelle Longmire, CEO, and co-founder of Medable. “Starting with eCOA, we are accelerating clinical trials while helping to improve data quality – ultimately enabling our vision of a one-day study start-up to help deliver effective treatments and cures to patients faster. In 2024, expect to see more innovative technologies and new ways of delivering streamlined, patient-centric trials from Medable.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics